Core Scientific, Inc.
CORZQ
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -35.69% | -1,006.45% | -8,592.18% | 54,401.80% | 55.00% |
| Total Depreciation and Amortization | -5.78% | 21.56% | 51.63% | 46.71% | -55.24% |
| Total Amortization of Deferred Charges | 85.37% | -- | -- | -- | -21.91% |
| Total Other Non-Cash Items | 82.53% | 635.29% | 943.26% | -230.82% | 6.67% |
| Change in Net Operating Assets | -158.56% | -26.16% | -11.15% | 25.23% | -160.66% |
| Cash from Operations | -36.39% | 5.13% | -93.32% | 11.19% | -81.29% |
| Capital Expenditure | -146.96% | -1,036.91% | -1,234.04% | -1,972.38% | 91.70% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -671.43% | 47.62% | 87.24% | 76.97% | -99.06% |
| Cash from Investing | -1,320.25% | -989.26% | -414.38% | -1,610.54% | 101.69% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 25.45% | -1,618.79% | -56.39% | -1,590.11% | -10.32% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 3,369.23% | 1,284.58% | -52.70% | 5,424.49% | -148.04% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 10,014.08% | 1,322.57% | -329.93% | 161.36% | -60.50% |
